BNF

Ref: https://www.pharmacyregulation.org/53-registration-assessment-framework

BNF CHAPTERS: REVISION NOTES

Chapter 1 – GI

Chapter 2 – CVS

Chapter 3 – Respiratory

Chapter 4 – Nervous

Chapter 5 – Infection

Chapter 6 – Endocrine

Chapter 7 – Genito-urinary

Chapter 8 – Malignant disease

Chapter 9 – Blood and nutrition

Chapter 10 – Muskuloskeletal

Chapter 11 – Eye

Chapter 12 – Ear, Nose, and Oropharynx

Chapter 13 – Skin

Chapter 14 – Vaccines

Chapter 15 – Anaesthesia

Chapter 17 – Summaries

A list of some of the topics/subjects that are covered in the BNF:

•   E numbers
•   Latin abbreviations
•   Abbreviations and symbols used in the BNF
•   Drug treatment for medical emergencies in the community
•   Resuscitation Council (UK) adult advanced life support algorithm
•   Table showing mean values for weight, height and gender by age
•   Approximate weight conversion chart
•   Non-medical prescribing
•   Nurse Prescribers’ Formulary
•   Dental Practitioners’ Formulary
•   Cautionary and advisory labels for dispensed medicines
•   Wound management products and elasticated garments
•   Borderline substances – ACBS
•   Intravenous additives
•   Drug interactions
•   Drugs in pregnancy
•   Drugs in breast-feeding
•   Prescribing in renal impairment
•   Prescribing in hepatic impairment
•   Drugs and driving
•   Reporting of suspected adverse drug reactions through the Yellow Card

Scheme

•   MHRA/CHM advice
•   Prescribing for children
•   Palliative care prescribing
•   Drug prescribing for the elderly
•   Prescribing in dental practice
•   Drugs and sport
•   Treatment of poisoning e.g. paracetamol poisoning treatment graph
•   Sugar-free oral liquid preparations

•   Extemporaneous preparation
•   Oral syringes
•   EEA prescriptions
•   Patient group direction (PGD)
•   Emergency supply of medicines
•   Prescription requirements for controlled drugs
•   Classification of controlled drugs by schedule
•   Low Na+ antacids
•   Regimens for Helicobacter pylori eradication
•   Prescribing for patients with a stoma
•   Classification of anti-arrhythmic drugs
•   Thresholds and targets for treatment of hypertension
•   Indications and target INRs for warfarin
•   Management of stable angina, NSTEMI and STEMI
•   Management of acute and chronic asthma based on recommendations

from the British Thoracic Society and SIGN

•   Use of inhaled therapies in COPD based on recommendations of NICE
•   Anaphylaxis and angioedema treatment
•   IM adrenaline (epinephrine) dose for the emergency treatment ofanaphylaxis
•   Standard and high dose inhaled corticosteroids
•   Treatment of croup
•   Equivalent doses of benzodiazepines
•   Equivalent doses of oral and depot antipsychotics
•   Status epilepticus
•   Notifiable diseases
•   Summary of antibacterial therapy and prophylaxis
•   Tuberculosis treatment
•   Prophylaxis against malaria
•   HbA1c equivalent values
•   Drivers with diabetes
•   Equivalent anti-inflammatory doses of corticosteroids
•   HRT risk table
•   Prescribing drugs for G6PD-deficient individuals
•   Electrolyte concentrations – IV fluids
•   Electrolyte content – gastrointestinal secretions
•   Electrolyte concentrations – infusion fluids for parenteral feeding
•   Drugs unsafe for use in patients with acute porphyrias
•   Excipients in eye drops
•   Suitable quantities of dermatological and corticosteroids preparations to be

prescribed for specific areas of the body

•   Suitable quantities of parasiticidal preparations for treatment of head lice,scabies and crab lice
•   Excipients in topical preparations that may be associated with sensitisation

•  Immunisation schedule
•  Surgery and long-term medication
•  Iron content of different iron salts
•  Phenylketonuria
•  Conversion from oral morphine to transdermal fentanyl

Please note this list is not intended to be a complete list of all the topics/subjects covered in the BNF or BNFC.